Groop PH - Search Results

1

Do sulfonylureas influence hepatic insulin clearance?

Groop LC, Groop PH, Stenman S, Saloranta C, Tötterman KJ, Fyhrquist F, Melander A. Groop LC, et al. Among authors: groop ph. Diabetes Care. 1988 Sep;11(8):689-90. doi: 10.2337/diacare.11.8.689. Diabetes Care. 1988. PMID: 3065007 No abstract available.

2

Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration.

Forsblom CM, Groop PH, Ekstrand A, Groop LC. Forsblom CM, et al. Among authors: groop lc, groop ph. BMJ. 1992 Oct 31;305(6861):1051-3. doi: 10.1136/bmj.305.6861.1051. BMJ. 1992. PMID: 1467683 Free PMC article.

3

The effect of exercise on urinary excretion of different size proteins in patients with insulin-dependent diabetes mellitus.

Groop L, Stenman S, Groop PH, Mäkipernaa A, Teppo AM. Groop L, et al. Among authors: groop ph. Scand J Clin Lab Invest. 1990 Sep;50(5):525-32. doi: 10.3109/00365519009089167. Scand J Clin Lab Invest. 1990. PMID: 2122516

4

Combined insulin-sulfonylurea therapy in treatment of NIDDM.

Groop LC, Groop PH, Stenman S. Groop LC, et al. Among authors: groop ph. Diabetes Care. 1990 Aug;13 Suppl 3:47-52. doi: 10.2337/diacare.13.3.47. Diabetes Care. 1990. PMID: 2209344 Review.

5

Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.

Groop L, Luzi L, Melander A, Groop PH, Ratheiser K, Simonson DC, DeFronzo RA. Groop L, et al. Among authors: groop ph. Diabetes. 1987 Nov;36(11):1320-8. doi: 10.2337/diab.36.11.1320. Diabetes. 1987. PMID: 3117609

6

Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.

Groop L, Groop PH, Stenman S, Saloranta C, Tötterman KJ, Fyhrquist F, Melander A. Groop L, et al. Among authors: groop ph. Diabetes Care. 1987 Nov-Dec;10(6):671-8. doi: 10.2337/diacare.10.6.671. Diabetes Care. 1987. PMID: 3123184 Clinical Trial.

7

Effects of the combination of insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents.

Stenman S, Groop PH, Saloranta C, Tötterman KJ, Fyhrqvist F, Groop L. Stenman S, et al. Among authors: groop ph, groop l. Diabetologia. 1988 Apr;31(4):206-13. doi: 10.1007/BF00290586. Diabetologia. 1988. PMID: 3133266 Clinical Trial.

8

Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.

Groop L, Miettinen A, Groop PH, Meri S, Koskimies S, Bottazzo GF. Groop L, et al. Among authors: groop ph. Diabetes. 1988 Jan;37(1):99-103. doi: 10.2337/diab.37.1.99. Diabetes. 1988. PMID: 3275559

9

The effect of dexamethasone on the enteroinsular axis.

Groop PH, Groop LC, Tötterman KJ, Fyhrquist F. Groop PH, et al. Among authors: groop lc. Scand J Clin Lab Invest. 1987 Sep;47(5):491-5. Scand J Clin Lab Invest. 1987. PMID: 3310195

10

Treatment failures in patients with type 2 (non-insulin-dependent) diabetes.

Groop L, Groop PH, Koskimies S. Groop L, et al. Among authors: groop ph. Diabetologia. 1988 Mar;31(3):186-7. doi: 10.1007/BF00276855. Diabetologia. 1988. PMID: 3371579 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

529 results

Search Page

Filters